Aclaris Therapeutics (ACRS) Return on Capital Employed (QoQ) (2016 - 2026)

Aclaris Therapeutics (ACRS) Return on Capital Employed (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 193.00
Dec 31, 2025 4,303.00
Sep 30, 2025 -991.00
Jun 30, 2025 -1,276.00
Mar 31, 2025 844.00
Dec 31, 2024 -5,332.00
Sep 30, 2024 1,410.00
Jun 30, 2024 776.00
Mar 31, 2024 289.00
Dec 31, 2023 627.00
Sep 30, 2023 -807.00
Jun 30, 2023 -817.00
Mar 31, 2023 -748.00
Dec 31, 2022 -450.00
Sep 30, 2022 213.00
Jun 30, 2022 86.00
Mar 31, 2022 222.00
Dec 31, 2021 -711.00
Sep 30, 2021 246.00
Jun 30, 2021 2,931.00